Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Zachary L Skidmore
Affiliation
Washington University in St. Louis School of Medicine
ORCID
Career Start Year
2015
Papers
48
H Index
20
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36251745
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.
Blood Adv
2023
37910143
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma.
Cancer Res Commun
2023
37487666
Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment.
J Immunother Cancer
2023
37493986
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Blood Adv
2023
37810214
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer.
iScience
2023
36949070
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.
Nat Commun
2023
37034778
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer.
bioRxiv
2023
37266381
Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma.
Front Vet Sci
2023
36373660
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.
Nucleic Acids Res
2023
34780623
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma.
Blood
2022
35494251
Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer.
iScience
2022
35568002
Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers.
Cancer Genet
2022
35624339
A community approach to the cancer-variant-interpretation bottleneck.
Nat Cancer
2022
36273232
Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer.
Sci Rep
2022
34610950
Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis.
Cancer Discov
2022
33397681
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Clin Cancer Res
2021
35611186
<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines.
Cancer Res Commun
2021
33547198
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.
Clin Cancer Res
2021
33556121
Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.
PLoS One
2021
34506690
Exploring the Genomic Landscape of Cancer Patient Cohorts with GenVisR.
Curr Protoc
2021
34019588
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF.
PLoS Pathog
2021
34036230
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia.
JCO Precis Oncol
2021
34173924
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.
Breast Cancer Res Treat
2021
32665297
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Clin Cancer Res
2020
31902496
A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors.
Vet Microbiol
2020
30287923
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples.
Genet Med
2019
31685621
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
Proc Natl Acad Sci U S A
2019
31467059
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade.
Blood
2019
31390566
A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation.
Cell Rep
2019
31618044
Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.
JCO Clin Cancer Inform
2019
30429476
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.
Nat Commun
2018
30134176
Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity.
Cell Rep
2018
29891591
A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel <i>RARG</i>-<i>CPSF6</i> fusion.
Blood Adv
2018
30181556
The prognostic effects of somatic mutations in ER-positive breast cancer.
Nat Commun
2018
30224629
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.
Nat Commun
2018
28874413
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer.
Clin Cancer Res
2017
28138153
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer.
Nat Genet
2017
28434888
Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.
Bone
2017
28270497
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.
Clin Cancer Res
2017
27029710
A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Ann Oncol
2016
26563128
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.
Clin Cancer Res
2016
26531824
DGIdb 2.0: mining clinically relevant drug-gene interactions.
Nucleic Acids Res
2016
27681435
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.
Cell Rep
2016
27288499
GenVisR: Genomic Visualizations in R.
Bioinformatics
2016
27181063
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
Exp Hematol
2016
27058228
A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.
Blood Cancer J
2016
26158448
Genome Modeling System: A Knowledge Management Platform for Genomics.
PLoS Comput Biol
2015
26645048
Optimizing cancer genome sequencing and analysis.
Cell Syst
2015
1 - 48 of 48
Column Actions
Search
Recommended Authors
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year
2016
Number of shared co-authors
4
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year
2016
Number of shared co-authors
5
Reyka G Jayasinghe
Washington University in St Louis
Career Start Year
2015
Number of shared co-authors
26
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year
2014
Number of shared co-authors
1
Jiguang Wang
The Hong Kong University of Science and Technology
Career Start Year
2012
Number of shared co-authors
0
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
2011
Number of shared co-authors
2
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year
2011
Number of shared co-authors
0
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year
2010
Number of shared co-authors
3
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year
2009
Number of shared co-authors
1
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
3
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year
2009
Number of shared co-authors
17
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
1
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2008
Number of shared co-authors
0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year
2007
Number of shared co-authors
5
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
4
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
3
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year
2006
Number of shared co-authors
6
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year
2006
Number of shared co-authors
3
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year
2006
Number of shared co-authors
3
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
16
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
4
Matthias Schlesner
University of Augsburg
Career Start Year
2004
Number of shared co-authors
5
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year
2004
Number of shared co-authors
13
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
1
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
22
Peter Van Loo
The Francis Crick Institute
Career Start Year
2003
Number of shared co-authors
4
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
7
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
0
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year
2000
Number of shared co-authors
36
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year
1999
Number of shared co-authors
22
row(s) 1 - 30 of 30
Collaborators
Obi L Griffith
Washington University
Co-authored papers
47
Malachi Griffith
Washington University
Co-authored papers
46
Kilannin Krysiak
Washington University School of Medicine
Co-authored papers
22
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
20
Elaine R Mardis
The Ohio State University
Co-authored papers
19
Erica K Barnell
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
16
Nicholas C Spies
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
15
Jason Walker
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
11
Kelsy C Cotto
Washington University
Co-authored papers
10
Jason Kunisaki
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
10
Richard K Wilson
The Ohio State University
Co-authored papers
10
Christopher A Miller
Washington University School of Medicine
Co-authored papers
10
Lee Trani
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
10
Benjamin J Ainscough
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers
9
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
9
Vincent Magrini
The Ohio State University
Co-authored papers
9
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Co-authored papers
8
Joshua F McMichael
Washington University
Co-authored papers
8
Alex H Wagner
Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis
Co-authored papers
8
David E Larson
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
8
Jasreet Hundal
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
8
Avinash Ramu
Washington University School of Medicine
Co-authored papers
8
Matthew J Ellis
Co-authored papers
7
Lukas D Wartman
Washington University School of Medicine in St. Louis
Co-authored papers
6
Ravindra Uppaluri
Brigham and Women's Hospital
Co-authored papers
6
Arpad M Danos
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers
5
Christopher A Maher
Washington University in St Louis
Co-authored papers
5
Megan M Richters
Washington University School of Medicine
Co-authored papers
5
James M Eldred
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
5
Adam C Coffman
Washington University
Co-authored papers
5
1 - 30